- Topical drug delivery in dermatology includes administration of medications directly to the skin to treat a wide range of skin diseases and disorders. The market in Asia-Pacific is rapidly expanding due to growing incidences of eczema, psoriasis, acne, and fungal infections, particularly in urban and humid environments.
- Patient preference for pain-free, localized treatments and growing uptake of advanced formulation technologies such as nanogels and liposomal creams are shaping market dynamics. Accessibility through e-commerce and pharmacy chains has also increased product reach.
- India and China are leading the market due to large patient populations, increasing health expenditure, and active presence of both multinational and domestic pharmaceutical players.
- Japan and South Korea are also key markets due to their high dermatology awareness, tech-driven innovation, and cosmetic dermatology demand.
- Corticosteroids segment is expected to hold the largest share of 42.5%, due to their established use, efficacy in inflammation management, and wide prescription base across dermatology indications.
